The potential role of abnormal antibody responses in the clinical features of SS is also supported by genome-wide association studies showing that some of the most highly disease-associated genes are involved in B-cell function (e.g. BTK) and antigen presentation (e.g. MHC)53,54. This evidence concerns the gene HLA-C and synovial sarcoma.